Kenneth Bender, PharmD, MA

Investigators test methods of incorporating smaller, localized datasets to improve influenza outbreak forecasts and increase community preparedness.

New trial results show adding ribavirin to a sofosbuvir plus velpatasvir regimen is beneficial for the considered difficult-to-reach patient population.

Outcomes with lacosamide monotherapy for focal seizures in real-world practice were similar to clinical trials but varied with antiepileptic drug history.

Prevalence of hypertension in HIV-positive persons is not attributed to antiretroviral drug treatment in largest adverse event surveillance study.

A combination of raltegravir plus boosted protease inhibitor was found equal to triple antiretroviral combination for HIV even in patients with previous treatment failure.

Young people who inject drugs tell why they do not—or cannot— receive treatment for hepatitis C virus infection.

Severe influenza was found to be an independent risk factor for invasive aspergillosis in the largest study conducted on the concurrent pulmonary infections.

A retrospective review finds HIV post-exposure prophylaxis is often prescribed outside of guidelines’ recommendations in response to patients' emotional stress.

Eslicarbazepine in combination with lamotrigine is better tolerated than when combined with carbamazepine for focal seizures.

Levetiracetam found superior to carbamazepine and valproate sodium in reducing Rolandic discharges on EEG of children with Rolandic epilepsy.

In absence of head-to-head trials between 2nd and 3rd generation antiepileptic drugs, a meta-analysis was used to identify suitable agents for monotherapy.

How the therapy is proving capable of giving patients the opportunity to slow down disease progression, while potentially increasing the health outcomes of patients and saving money.

Hispanic/Latina women in the US access HIV treatment at same rates as men despite facing greater challenges.

Statistical analysis reveals cardiac effects of individual antiretrovirals in combination treatments for children infected with HIV perinatally.

Switching antiepileptic drug manufacturer was found to increase the risk of seizure recurrence in a German population, contrary to findings in the US.

The investigators determined that hepatitis C co-infection increased risk for all-cause mortality in patients with HIV receiving antiretroviral treatment by 4.3%.

Mathematical modeling projects that Australia could achieve World Health Organization targets for elimination of HCV in a decade. What can the US learn from their efforts?

Individuals with hepatitis C infection who use cannabis were also found to have lower total healthcare costs than non-users.

How can caregivers improve their management of treatments—both in cost and in availability—for children in need of help due to asthma.

Switching to the smallest complete daily pill for HIV from other regimens with different components of the same drug classes proved advantageous for patients with HIV, treating the infection with less adverse effects.

The combination of montelukast and budesonide was found more effective than budesonide alone in children with chronic cough-variant asthma in a China retrospective study.

Investigators found that asthma symptom severity results from the interaction of genetic susceptibility to pollution together with the severity of pollution exposure.

The risk of acute coronary syndrome recurring after hospitalization was not found to be increased in individuals infected with HIV.

Study of abrupt versus gradual reduction of nicotine informs FDA-proposed rule on reducing cigarette nicotine to "minimally addictive" levels.

The treatment may be most appropriate for toddlers who are admitted to the hospital, have severe allergies, or are seen in the emergency department.

One Cleveland Clinic practitioner describes his real-world experience with the use of mepolizumab in patients with severe eosinophilic asthma.

Results of an analysis indicate suicidal behavior occurred more often in patients taking an efavirenz-based treatment for HIV than in a control group that had not started treatment.

The first darunavir-based single tablet regimen for HIV has shown positive results in trials as both a switch therapy and for the rapid initiation of treatment in those who are newly diagnosed.

Tardive Dyskinesia Assessment Workshop members confirm the AIMS to be a valid measure of TD, but recommends alternative analyses to gauge treatments.

Experts argue that oral corticosteroids should be available at home for early use in asthma exacerbation.